Concepedia

Author

Thiemo J. A. van Nijnatten

Maastricht UniversityORCID

Also Known As

Loes F.S. Kooreman, T J A van Nijnatten, T. J. A. Van Nijnatten, T. J. A. van Nijnatten, T. Nijnatten, T.J.A. Van Nijnatten, T.J.A. van Nijnatten, Thiemo J.A. van Nijnatten, Thiemo J A van Nijnatten, Thiemo J. A. van Nijnatten

96

Publications

2.2K

Citations

24

H-Index

45

Concepts

All Affiliations

Maastricht UniversityZuyderland Medisch CentrumUniversity Medical CenterUniversity Medical Center UtrechtMaastricht University Medical Centre
TJ

About

Thiemo J. A. van Nijnatten is an author at Maastricht University specializing in radiology, breast cancer, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

448

2

Health Sciences

7

7

330

3

Engineering

6

6

205

4

Biostatistics

2

2

120

5

Biomedical Engineering

1

1

26

Thiemo J. A. van Nijnatten

×

30

Publications

1.3K

Citations

20

H-Index

YearCitations

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

B. Goorts, Thiemo J. A. van Nijnatten, Linda de Munck,

Breast Cancer Research and Treatment

2017

129

Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?

Toine M. Lodewick, Thiemo J. A. van Nijnatten, Ronald M. van Dam,

HPB

2014

127

Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy

Sanaz Samiei, Thiemo J. A. van Nijnatten, Linda de Munck,

Annals of Surgery

2018

108

A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study

Thiemo J. A. van Nijnatten, Janine M. Simons, Marjolein L. Smidt,

Clinical Breast Cancer

2017

104

Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer

Janine M. Simons, Thiemo J. A. van Nijnatten, Carmen C. van der Pol,

JAMA Surgery

2022

84

Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients

Thiemo J. A. van Nijnatten, Eline H. Ploumen, RJ. Schipper,

European Journal of Radiology

2016

83

MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variability

Renée W. Y. Granzier, N. M. H. Verbakel, Abdalla Ibrahim,

Scientific Reports

2020

80

Whole‐liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

Shengxiang Rao, Doenja M. J. Lambregts, R. S. Schnerr,

United European Gastroenterology Journal

2014

70

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

Thiemo J. A. van Nijnatten, Janine M. Simons, M. Moossdorff,

Breast Cancer Research and Treatment

2017

63

MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study

Renée W. Y. Granzier, Abdalla Ibrahim, Sergey Primakov,

Cancers

2021

40

Page 1